HAILEY ARMSTRONG: Open Payments
NPI 1326463175 · ALBERTVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,008 in 185 payments from 26 companies in 2025. Trend: 2023 $2,587 · 2024 $2,854 · 2025 $3,008
Food & beverage: $3,008
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $424 |
| Novo Nordisk Inc | 15 | $257 |
| AstraZeneca Pharmaceuticals LP | 14 | $246 |
| PFIZER INC. | 20 | $234 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $223 |
| Sumitomo Pharma America, Inc. | 22 | $205 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $197 |
| Janssen Scientific Affairs, LLC | 2 | $169 |
| GlaxoSmithKline, LLC. | 10 | $157 |
| Lilly USA, LLC | 8 | $151 |
Products named: VRAYLAR, CAPLYTA, TREMFYA, GEMTESA, Kerendia, TRELEGY ELLIPTA, MOUNJARO, FARXIGA.
Industry payments across AL — which companies pay providers there.
